Cargando…

Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis

BACKGROUND: New therapeutic approaches with biologic agents such as anti-cytokine antibodies are currently on trial for the treatment of asthma, rhinosinusitis or allergic diseases necessitating patient selection by biomarkers. Allergic rhinitis (AR), affecting about 20 % of the Canadian population,...

Descripción completa

Detalles Bibliográficos
Autores principales: König, Katrin, Klemens, Christine, Eder, Katharina, San Nicoló, Marion, Becker, Sven, Kramer, Matthias F., Gröger, Moritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580351/
https://www.ncbi.nlm.nih.gov/pubmed/26401140
http://dx.doi.org/10.1186/s13223-015-0093-x
_version_ 1782391381269938176
author König, Katrin
Klemens, Christine
Eder, Katharina
San Nicoló, Marion
Becker, Sven
Kramer, Matthias F.
Gröger, Moritz
author_facet König, Katrin
Klemens, Christine
Eder, Katharina
San Nicoló, Marion
Becker, Sven
Kramer, Matthias F.
Gröger, Moritz
author_sort König, Katrin
collection PubMed
description BACKGROUND: New therapeutic approaches with biologic agents such as anti-cytokine antibodies are currently on trial for the treatment of asthma, rhinosinusitis or allergic diseases necessitating patient selection by biomarkers. Allergic rhinitis (AR), affecting about 20 % of the Canadian population, is an inflammatory disease characterised by a disequilibrium of T-lymphocytes and tissue eosinophilia. Aim of the present study was to describe distinct cytokine patterns in nasal secretion between seasonal and perennial AR (SAR/PAR), and healthy controls by comparing cytokines regulating T-cells or stimulating inflammatory cells, and chemokines. METHODS: Nasal secretions of 44 participants suffering from SAR, 45 participants with PAR and 48 healthy controls were gained using the cotton wool method, and analysed for IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12, IL-13, IL-17, GM-CSF, G-CSF, IFN-γ, MCP-1, MIP-1α, MIP-1β, eotaxin, and RANTES by Bio-Plex Cytokine Assay as well as for ECP and tryptase by UniCAP-FEIA. RESULTS: Participants with SAR or PAR presented elevated levels of tryptase, ECP, MCP-1, and MIP-1β, while values of GM-CSF, G-CSF, IL-1β, and IL-6 did not differ from the controls. Increased levels of IL-5, eotaxin, MIP-1α, and IL-17 and decreased levels of IFN-γ, IL-12 and IL-10 were found in SAR only. RANTES was elevated in SAR in comparison to PAR. Interestingly, we found reduced levels of IL-4 in PAR and of IL-13 in SAR. CONCLUSIONS: Elevated levels of proinflammatory cytokines were seen in both disease entities. They were, however, more pronounced in SAR, indicating a higher degree of inflammation. This study suggests a downregulation of T(H)1 and T(reg)-lymphocytes and an upregulation of T(H)17 in SAR. Moreover, the results display a prominent role of eosinophils and mast cells in AR. The observed distinct cytokine profiles in nasal secretion may prove useful as a diagnostic tool helping to match patients to antibody therapies.
format Online
Article
Text
id pubmed-4580351
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45803512015-09-24 Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis König, Katrin Klemens, Christine Eder, Katharina San Nicoló, Marion Becker, Sven Kramer, Matthias F. Gröger, Moritz Allergy Asthma Clin Immunol Research BACKGROUND: New therapeutic approaches with biologic agents such as anti-cytokine antibodies are currently on trial for the treatment of asthma, rhinosinusitis or allergic diseases necessitating patient selection by biomarkers. Allergic rhinitis (AR), affecting about 20 % of the Canadian population, is an inflammatory disease characterised by a disequilibrium of T-lymphocytes and tissue eosinophilia. Aim of the present study was to describe distinct cytokine patterns in nasal secretion between seasonal and perennial AR (SAR/PAR), and healthy controls by comparing cytokines regulating T-cells or stimulating inflammatory cells, and chemokines. METHODS: Nasal secretions of 44 participants suffering from SAR, 45 participants with PAR and 48 healthy controls were gained using the cotton wool method, and analysed for IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12, IL-13, IL-17, GM-CSF, G-CSF, IFN-γ, MCP-1, MIP-1α, MIP-1β, eotaxin, and RANTES by Bio-Plex Cytokine Assay as well as for ECP and tryptase by UniCAP-FEIA. RESULTS: Participants with SAR or PAR presented elevated levels of tryptase, ECP, MCP-1, and MIP-1β, while values of GM-CSF, G-CSF, IL-1β, and IL-6 did not differ from the controls. Increased levels of IL-5, eotaxin, MIP-1α, and IL-17 and decreased levels of IFN-γ, IL-12 and IL-10 were found in SAR only. RANTES was elevated in SAR in comparison to PAR. Interestingly, we found reduced levels of IL-4 in PAR and of IL-13 in SAR. CONCLUSIONS: Elevated levels of proinflammatory cytokines were seen in both disease entities. They were, however, more pronounced in SAR, indicating a higher degree of inflammation. This study suggests a downregulation of T(H)1 and T(reg)-lymphocytes and an upregulation of T(H)17 in SAR. Moreover, the results display a prominent role of eosinophils and mast cells in AR. The observed distinct cytokine profiles in nasal secretion may prove useful as a diagnostic tool helping to match patients to antibody therapies. BioMed Central 2015-09-22 /pmc/articles/PMC4580351/ /pubmed/26401140 http://dx.doi.org/10.1186/s13223-015-0093-x Text en © König et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
König, Katrin
Klemens, Christine
Eder, Katharina
San Nicoló, Marion
Becker, Sven
Kramer, Matthias F.
Gröger, Moritz
Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
title Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
title_full Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
title_fullStr Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
title_full_unstemmed Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
title_short Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
title_sort cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580351/
https://www.ncbi.nlm.nih.gov/pubmed/26401140
http://dx.doi.org/10.1186/s13223-015-0093-x
work_keys_str_mv AT konigkatrin cytokineprofilesinnasalfluidofpatientswithseasonalorpersistentallergicrhinitis
AT klemenschristine cytokineprofilesinnasalfluidofpatientswithseasonalorpersistentallergicrhinitis
AT ederkatharina cytokineprofilesinnasalfluidofpatientswithseasonalorpersistentallergicrhinitis
AT sannicolomarion cytokineprofilesinnasalfluidofpatientswithseasonalorpersistentallergicrhinitis
AT beckersven cytokineprofilesinnasalfluidofpatientswithseasonalorpersistentallergicrhinitis
AT kramermatthiasf cytokineprofilesinnasalfluidofpatientswithseasonalorpersistentallergicrhinitis
AT grogermoritz cytokineprofilesinnasalfluidofpatientswithseasonalorpersistentallergicrhinitis